EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial
Clinical trial NCT06897488 · RECRUITING
Trial details
- NCT number
- NCT06897488
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-17
- Primary completion
- 2028-12-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.